Should Postmastectomy Radiotherapy to the Chest Wall and Regional Lymph Nodes Be Standard for Patients with 1–3 Positive Lymph Nodes?

Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden

(2011) Paul McGale et al.   RADIOTHERAPY AND ONCOLOGY

Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925)

(2010) Oscar Matzinger et al.   ACTA ONCOLOGICA

Increased use of regional radiotherapy is associated with improved outcome in a population-based cohort of women with breast cancer with 1–3 positive nodes

(2010) Elaine S. Wai et al.   RADIOTHERAPY AND ONCOLOGY

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009

(2009) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

Estrogen Receptor, Progesterone Receptor, HER-2, and Response to Postmastectomy Radiotherapy in High-Risk Breast Cancer: The Danish Breast Cancer Cooperative Group

(2008) Marianne Kyndi et al.   JOURNAL OF CLINICAL ONCOLOGY

High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: A subgroup analysis of DBCG 82 b&c

(2008) Marianne Kyndi et al.   RADIOTHERAPY AND ONCOLOGY

DEGRO Practical Guidelines for Radiotherapy of Breast Cancer II

(2008) Marie-Luise Sautter-Bihl et al.   STRAHLENTHERAPIE UND ONKOLOGIE